Generation of ‘X-Men’ superhumans could become a reality in 30 years thanks to advances in gene science, say MoD experts
- Experts warn of ‘genetic inequality’ if advances are unequally shared
- Report says ‘human augmentation’ is likely to increase over next 30 years
- Details released following a Freedom of Information request
The MoD’s Development Concepts and Doctrine Centre warn however that ‘genetic inequality’ could result from advancements in biology being unequally shared across society.
Mutant: MoD experts have suggested a generation of genetically-modified ‘X-Men’ superhumans, such as Wolverine, could be a reality by 2045
The centre met last summer for a two-day summit, featuring experts from government, industry and universities. The details have been released following a Freedom of Information request by The Sun.
It was reported during the summit, held to predict what would happen in the future, that: ‘Advancements in gene technology could lead to a class of genetically superior humans by 2045.
‘Human augmentation is likely to increase over the next 30 years.
‘Discussions highlighted that it is possible that advances in biology, unequally shared across society, could generate genetic inequality.’
The X-Men are a team of mutant superheroes created by writer Stan Lee and artist Jack Kirby, who first appeared in Marvel Comics in 1963.
The mutants use their powers for the benefit of humanity, despite an ever-growing anti-mutant sentiment among mankind.
The comics were turned into a highly-successful film series, featuring Hugh Jackman as Wolverine, Halle Berry as Storm, Ian McKellan as Magneto and Patrick Stewart as Professor X.
Previously unknown human population boom revealed by DNA: Massive expansion occurred 40,000 years ago
- Scientists guess that baby boom occurred as our ancestors adapted to life away from the coasts
By Damien Gayle
DNA sequencing has revealed a previously unknown human population boom between 40,000 and 50,000 years ago, a new study claims.
The sequencing of the Y chromosomes from 36 men has revealed a ten-fold increase in the number of genetic markers nearly 20,000 years after our ancestors first left Africa.
Scientists believe the expansion could have occurred as our ancestors adapted to more rugged environments, allowing them to spread inland from coastal areas.
Baby boom: New analysis of DNA has revealed a previously unknown human population explosion between 40,000 and 50,000 years ago
‘We have always considered the expansion of humans out of Africa as being the largest population expansion of modern humans, but our research questions this theory,’ said Wei Wei of the West China University of Medical Sciences.
‘The out-of-Africa expansion, which happened approximately 60,000 years ago, was extremely large in geographical terms with humans spreading around the globe.
‘Now we’ve found a second wave of expansion that is much larger in terms of human population growth and occurred over a very short period, somewhere between 40,000 to 50,000 years ago.’
Categories: Uncategorized Tags: bigfoot dna, CGA Platform, Complete Genomics Initial Public Offering, DNA sequencing platform, genetics, human dna sequencing, neanderthals, Previously unknown human population boom revealed DNA Massive expansion occurred 40 000 years ago, whole genome sequencing
Here is the definition taken from the Human Genome Project, “A genome is the complete collection of an organism’s genetic material. The human genome is composed of about 20,000 to 25,000 genes located on the 23 pairs of chromosomes in a human cell.
A single human chromosome may contain more than 250 million DNA base pairs, and scientists estimate that the entire human genome consists of about 3 billion base pairs.
In the past eighteen months, scientists discovered more than 100 genetic variations that affect older people, such as: type 2 diabetes, asthma, Alzheimer’s disease, osteoporosis, high blood pressure and heart disease.
Genetic science is moving so fast that people now in their 60′s-80′s will see medical innovations that will touch their lives.
Francis Collins, MD, a leader in the Project, was astounded to see the huge amount of information derived from the genome, particularly in regards to older people.
As an example he cited age-related Macular degeneration, an eye disease troubling almost 2 million, visually impaired Americans. “Using new genomic tools we’ve discovered two genes that account for about 60% of the risk- the rest is smoking. But we were surprised. These genes are involved in inflammation, and everybody was thinking macular degeneration was caused by aging in the back of the eye.”
Macular degeneration tests are now being made using anti-inflammatory drugs, a complete change in the way it was formerly viewed.
Many scientists believe that the Human Genome Project has the potential to revolutionize both therapeutic and preventive medicine by providing insights into the basic biochemical processes that underlie many human diseases.
Categories: Uncategorized Tags: bioinformatics, cancer research, cancer sequencing, CGA Platform, Complete Genomics Analysis Platform, Complete Genomics Initial Public Offering, Complete Genomics IPO, DNA, DNA sequencing platform, dna sequencing services, genome biology, genome research, genome sequencing, genome sequencing technology, genome-based research, human dna sequencing, Human Genome, human genome research, human genome sequencing, human genome sequencing science, sequencing technology, whole genome amplification, whole genome sequencing
It was once thought that the human genome would never be completely mapped out because it was much too complex. The human genome project found that, while complex, human genomes are not as complex as some very undistinguished creatures such as the roundworm and fruit fly.
Nevertheless the breakthrough was enormous and caused an incredible stir among scientists and researchers worldwide, opening doors to research about humans that had never before been seen.
At the center of the breakthrough was Complete Genomics, a California research facility that caused the stir when it announced in 2009 that it had sequenced its first human genome. When they had finished it they submitted the data to the National Center for Biotechnology Information and scientists the world over clamored to see it.
Today Complete Genomics is a full-service life-sciences company. The DNA sequencing platform that they developed is used by researchers around the globe to analyze and sequence human genomes using their proprietary and data management software and their informatics.
When a researcher anywhere in the world needs a genome to be sequenced they send it to Complete Genomics for analysis in Mountain View, California. After sequencing the assembled sequences and variant reports are published and sent back to the various researchers who order them.
The proprietary software that Complete Genomics uses is adjusted for the study of human DNA exclusively, and they can provide researchers with genome variation files and also assembled sequences.
Today there are various research papers that have been submitted using the results found at Complete Genomics. For example, their research was responsible for finding which gene was responsible for Miller Syndrome, a rare craniofacial disorder that had struck 1 member of a family of four.
It’s an amazing time to be alive, to be sure, and Complete Genomics is at the forefront of amazing changes that will soon be taking place that only years ago were hard to even imagine. Their technology will ultimately allow researchers to help find and, possibly, cure many diseases that afflict mankind.
Categories: Complete Genomics Tags: bioinformatics, cancer research, cancer sequencing, CGA Platform, Complete Genomics Analysis Platform, Complete Genomics Initial Public Offering, Complete Genomics IPO, DNA sequencing platform, dna sequencing services, genome biology, genome research, genome-based research, human dna sequencing, Human Genome, human genome research, human genome sequencing, human genome sequencing science, sequencing technology, whole genome amplification, whole genome sequencing